Details for 2021178882

Up to date per 03.04.2026

Actions

Title / Product Name

DOSIERUNGSSCHEMA FÜR VALBENAZIN ZUR BEHANDLUNG VON HYPERKINETISCHEN BEWEGUNGSSTÖRUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021178882

EP Publication Number

3936130

E-Number

1656473

Language

PCT Number

Publication Date

12.01.2022 A

14.02.2024 B1

Registration Date

14.02.2024

AT Publication Date

15.03.2024

Application Date

06.05.2015

Registration Number

Priorities

06.05.2014

201461989240 P

IPC

A61K 31/473 20060101AFI20211116BHEP

Maximum Duration of Protection

06.05.2035

Owner

Neurocrine Biosciences, Inc.6027 Edgewood Bend Court San Diego, California 92130US

Representative

No representatives present

Inventor

O'BRIEN, Christopher San Diego, 92130US

Information about Fees